Stephen K. Doberstein, SVP & Chief Scientific Officer at NEKTAR THERAPEUTICS (NKTR), sold 6,870 shares at $83.39 ($573K) on 2018-05-16, disclosed to the SEC on 2018-05-18.
Open-market sale of $573k NKTR by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.39 | 3,435 | $286K | 50.0% |
| 2 | $83.39 | 3,435 | $286K | 50.0% |
| Total | $83.39 avg | 6,870 | $573K | 100% |
| Filing → |
| NKTR | SELL | 2019-05-17 | $217K | — | Filing → |
| NKTR | SELL | 2019-02-21 | $281K | — | Filing → |
| NKTR | SELL | 2018-11-19 | $173K | — | Filing → |